Skip to content
Environment, Medical Health Aged Care

Expert available for comment – air pollution in NYC

UNSW Sydney < 1 mins read

New York City is making headlines with air pollution rated among the world's worst. Smoke has wafted down from wildfires across Quebec, containing small particulate matter that is damaging to respiratory health. 

 

Air pollution expert Dr Christine Cowie is available for media enquiries. Dr Cowie is an environmental epidemiologist and Senior Research Fellow with the UNSW South West Sydney Clinical School and the Woolcock Institute of Medical Research (WIMR) and is affiliated with the NHMRC CRE Centre for Safe Air.

Dr Cowie's major research focus is in quantifying the health effects of air pollution exposures and developing appropriate tools for exposure measurement. Dr Cowie has a special interest in urban exposures including the health effects of traffic related air pollution, and more recently, the effects of woodsmoke pollution, an unrecognised but highly significant urban source of pollution. Additional research interests also include the effects of indoor emissions from gas appliances, bushfire smoke and investigating the potential for health impacts associated with energy transitions.

Dr Cowie can be contacted on [email protected] and 0411738528.

More from this category

  • Medical Health Aged Care
  • 04/03/2026
  • 08:56
Monash University

Monash University and Seaport Therapeutics Awarded up to $21 Million AUD from ARPA-H to Advance GlyphCeleTM, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash Institute of Pharmaceutical Sciences (MIPS), to address dysfunctional gut lymphatics linked to metabolic disease and pancreatic cancer. Monash University has announced the award of support from the Advanced Research Projects Agency for Health (ARPA-H) to advance an oral prodrug of celecoxib – using the GlyphTM platform and designed to deliver therapy directly to the gut lymphatics – aiming to improve lymphatic function and advance the treatment of metabolic disease and pancreatic cancer by directly addressing local inflammation and lymphatic dysfunction. The…

  • Environment
  • 04/03/2026
  • 08:26
Lithium Royalty Corp.

Lithium Royalty Corp. Announces Receipt of Final Court Approval for Plan of Arrangement with Altius Minerals Corporation

TORONTO–BUSINESS WIRE– Lithium Royalty Corp. (the “Company” or “LRC”) (TSX: LIRC) is pleased to announce that it has obtained a final order (the “Final…

  • Contains:
  • Medical Health Aged Care, Women
  • 04/03/2026
  • 06:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer

MEDIA RELEASE: Wednesday,4March2025 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) announces the local opening of theSTRIVEclinical trial– Stratification of Vulvar Squamous Cell Carcinoma by HPV and p53 status to Guide Excisionclinical trial (CCTG Protocol VU.2; ANZGOG Protocol ANZGOG2109/2021). STRIVErepresentsan important stepforward in advancing evidence-based surgical management for women diagnosed with vulvar squamous cell carcinoma (VSCC). About the STRIVE Trial STRIVE is an international, prospective, stratification study designed to refine surgical decision-making for patients withprimary vulvar squamous cell carcinoma(VSCC) based ontumourbiology. The study is led globally by the CCTG and led…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.